cfrno 21 cfr part 872 cfrno rindock docket 93n0470 rindock medic devic classif temporomandibular joint implant agenc agenc food drug administr hh agenc action action repropos rule action summari summari food drug administr fda repropos classifi two temporomandibular joint tmj implant mandibular condyl prosthesi glenoid fossa prosthesi class iii premarket approv agenc issu repropos reflect recommend dental product panel respect classif devic comment receiv origin propos remain part record propos action taken feder food drug cosmet act act amend medic devic amend 1976 amend safe medic devic act 1990 smda summari date date written comment april 15 1994 commission food drug propos final regul base propos becom effect 30 day date public feder regist date address address submit written comment docket manag branch hfa305 food drug administr rm 123 12420 parklawn dr rockvil md 20857 address inform contact joseph sheehan center devic radiolog health hfz84 food drug administr 2094 gaither rd rockvil md 20850 3015944765 supplem supplementari inform background act amend amend pub l 94295 smda pub l 101629 establish comprehens system regul medic devic intend human use section 513 act 21 u c 360c establish three categori class devic depend regulatori control need provid reason assur safeti effect three categori devic class gener control class ii special control class iii premarket approv devic commerci distribut may 28 1976 amend classifi section 513 act fda done follow 1 receiv recommend devic panel fda advisori committe 2 publish panel recommend comment along propos regul classifi devic 3 publish final regul classifi devic devic first offer commerci distribut may 28 1976 substanti equival devic classifi scheme also classifi class devic substanti equival devic commerci distribut prior may 28 1976 substanti equival preamend devic classifi statut class iii without fda rulemak proceed agenc determin whether new devic substanti equival previous offer devic mean premarket notif procedur section 510 k act 21 u c 360 k part 807 regul 21 cfr part 807 base upon recommend fda dental devic classif panel agenc publish final regul classifi 110 preamend dental devic august 12 1987 52 fr 30082 tmj prosthes inadvert omit dental devic consid reclassif panel agenc base upon recommend dental product panel follow april 21 1989 meet fda propos septemb 18 1992 57 fr 43165 classifi interarticular disc prosthesi mandibular condyl prosthesi glenoid fossa prosthesi total temporomandibular prosthesi class iii april 1989 meet dental product panel panel make recommend regard classif glenoid fossa prosthesi mandibular condyl prosthesi panel note howev implant glenoid fossa use natur occur mandibular condyl implant mandibular condyl use natur occur glenoid fossa februari 11 1993 meet dental product panel recommend mandibular condyl prosthesi glenoid fossa prosthesi classifi class iii base upon recommend fda repropos classif two devic class iii effect classifi devic class iii requir manufactur devic submit fda premarket approv applic pma date set futur regul section 515 b act 21 u c 360e b applic must includ suffici valid scientif evid provid reason assur devic safe effect condit use prescrib recommend suggest propos label pma class iii preamend devic must submit within 30 month final classif 90 day agenc publish final regul 21 u c 360e b requir pma devic whichev later fda advis manufactur devic classifi devic classifi class iii agenc intend requir pma file devic earliest date allow statut therefor pma approv investig devic exempt would requir devic last day 30th month follow final classif class iii ii dental product panel recommend glenoid fossa prosthesi dental product panel fda advisori committe made follow recommend regard classif glenoid fossa prosthesi 1 identif glenoid fossa prosthesi devic intend implant temporomandibular joint augment glenoid fossa provid articul surfac head natur occur mandibular condyl 2 recommend classif class iii premarket approv dental product panel recommend premarket approv glenoid fossa prosthesi high prioriti 3 summari reason recommend dental product panel recommend glenoid fossa prosthesi classifi class iii panel believ premarket approv necessari provid reason assur safeti effect devic panel also believ devic present potenti unreason risk ill injuri patient insuffici inform exist determin gener control either alon combin special control applic class ii devic suffici provid reason assur safeti effect devic therefor devic subject premarket approv ensur manufactur devic develop suffici inform provid reason assur safe effect 4 summari data recommend base dental product panel base recommend panel member person knowledg clinic experi devic present panel member interest parti ref 1 5 risk health follow risk associ glenoid fossa prosthesi implant loosen displac screw use anchor implant may loosen result implant loosen displac caus chang bite difficulti chew limit joint function unpredict wear implant compon ref 2 5 b degen chang natur articul surfac implant breakdown may result eros resorpt head mandibular condyl glenoid fossa eros resorpt may result intens pain chang bite difficulti chew limit joint function perfor middl cranial fossa ref 2 5 c foreign bodi reaction implant deterior migrat may result foreign bodi reaction character multinucl giant cell ref 2 5 infect implant cannot properli steril infect may result e loss implant integr implant materi unabl withstand mechan load implant torn perfor delamin fragment fatigu fractur result failur devic function properli ref 2 5 f corros implant materi subject corros toxic element may migrat variou part bodi g chronic pain degen chang within articular surfac compon temporomandibular joint due implant breakdown may result chronic pain ref 2 5 h chang contralater joint unilater placement implant may result deleteri effect contralater joint malocclus placement devic may produc improp occlus relationship fda agre dental product panel classif recommend propos glenoid fossa prosthesi classifi class iii premarket approv fda believ insuffici inform exist identifi proper materi design glenoid fossa prosthesi therefor fda propos premarket approv glenoid fossa prosthesi given high prioriti act requir agenc classifi class iii devic present potenti unreason risk ill injuri unless determin premarket approv necessari provid reason assur safeti effect devic fda believ devic present potenti unreason risk ill injuri patient adequ data ensur safe effect use devic agenc believ gener control either alon combin special control applic class ii devic insuffici provid reason assur safeti effect devic b mandibular condyl prosthesi dental product panel fda advisori committe made follow recommend regard classif mandibular condyl prosthesi 1 identif mandibular condyl prosthesi devic intend implant human jaw replac mandibular condyl articul within natur occur glenoid fossa 2 recommend classif class iii premarket approv dental product panel recommend premarket approv mandibular condyl prosthesi high prioriti 3 summari reason recommend dental product panel recommend mandibular condyl prosthesi classifi class iii panel believ premarket approv necessari provid reason assur safeti effect devic panel also believ devic present potenti unreason risk ill injuri patient insuffici inform exist determin gener control either alon combin special control applic class ii devic suffici provid reason assur safeti effect devic therefor devic subject premarket approv ensur manufactur devic develop suffici inform provid reason assur safe effect 4 summari data recommend base dental product panel base recommend panel member person knowledg clinic experi devic present panel member interest parti ref 1 5 risk health follow risk associ mandibular condyl prosthesi implant loosen displac screw use anchor implant may loosen result implant loosen displac caus chang bite difficulti chew limit joint function unpredict wear implant compon ref 2 5 b degen chang natur articul surfac implant breakdown may result eros resorpt head mandibular condyl glenoid fossa eros resorpt may result intens pain chang bite difficulti chew limit joint function perfor middl cranial fossa ref 2 5 c foreign bodi reaction implant deterior migrat may result foreign bodi reaction character multinucl giant cell ref 2 5 infect implant cannot properli steril infect may result e loss implant integr implant materi unabl withstand mechan load implant torn perfor delamin fragment fatigu fractur result failur devic function properli ref 2 5 f corros implant materi subject corros toxic element may migrat variou part bodi g chronic pain degen chang within articular surfac compon temporomandibular joint due implant breakdown may result chronic pain ref 2 5 h chang contralater joint unilater placement implant may result deleteri effect contralater joint malocclus placement devic may produc improp occlus relationship fda agre dental product panel classif recommend propos mandibular condyl prosthesi classifi class iii premarket approv fda believ insuffici inform exist identifi proper materi design mandibular condyl prosthesi therefor fda propos premarket approv mandibular condyl prosthesi given high prioriti act requir agenc classifi class iii devic present potenti unreason risk ill injuri unless determin premarket approv necessari provid reason assur safeti effect devic fda believ devic present potenti unreason risk ill injuri patient adequ data ensur safe effect use devic agenc believ gener control either alon combin special control applic class ii devic insuffici provid reason assur safeti effect devic iii refer follow refer place display docket manag branch address may seen interest person 9 4 p monday friday 1 transcript dental product panel meet februari 11 1993 2 fontenot g j k kent vitro vivo wear perform tmj implant abstract intern associ dental research 1991 3 kent j n block comparison fep upe glenoid fossa prosthesi abstract intern associ dental research 1991 4 clinic inform vitek tmj interposit ipi implant vitek kent vk vitek kent 1 vk1 tmj implant vitek patient notif program fda public 1991 5 kent j n vk partial total joint reconstruct current concept tmj total joint replac univers medicin dentistri new jersey pp 18 march 1992 iv environment impact agenc determin 21 cfr 25 24 e 2 action type individu cumul signific effect human environ therefor neither environment assess environment impact statement requir v econom impact fda examin cost benefit propos rule classifi two tmj implant class iii accord execut order 12866 regulatori flexibl act pub l 96354 propos rule would impos new requir therefor fda conclud propos rule signific rule defin execut order 12866 accord regulatori flexibl act agenc certifi propos rule signific impact substanti number small busi list subject 21 cfr part 872 medic devic therefor feder food drug cosmet act author deleg commission food drug propos 21 cfr part 872 amend follow part 872_dental devic 1 author citat 21 cfr part 872 continu read follow author sec 501 510 513 515 520 701 feder food drug cosmet act 21 u c 351 360 360c 360e 360j 371 2 new 872 3950 872 3960 ad subpart read follow 872 3950 glenoid fossa prosthesi identif glenoid fossa prosthesi devic intend implant temporomandibular joint augment glenoid fossa provid articul surfac head natur occur mandibular condyl b classif class iii c date pma notic complet pdp requir effect date requir premarket approv establish see 872 3 872 3960 mandibular condyl prosthesi identif mandibular condyl prosthesi devic intend implant human jaw replac mandibular condyl articul within natur occur glenoid fossa b classif class iii c date pma notic complet pdp requir effect date requir premarket approv establish see 872 3 date februari 8 1994 supplem signer michael r taylor signer signjob deputi commission polici signjob frfile fr doc 943399 file 21194 8 45 frfile bill bill code 416001f bill